TCMP
MRK icon

Thrive Capital Management (Pennsylvania)’s Merck MRK Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.93M Sell
41,019
-3,269
-7% -$377K 1.08% 20
2025
Q4 		$4.66M Sell
44,288
-7,231
-14% -$679K 1.04% 19
2025
Q3 		$4.32M Buy
51,519
+6,117
+13% +$504K 1.12% 22
2025
Q2 		$3.59M Buy
45,402
+26,464
+140% +$2.1M 1.13% 18
2025
Q1 		$1.7M Sell
18,938
-8,252
-30% -$770K 1.02% 28
2024
Q4 		$2.7M Buy
27,190
+8,956
+49% +$923K 1.24% 22
2024
Q3 		$2.07M Buy
18,234
+15,007
+465% +$1.78M 0.98% 23
2024
Q2 		$400K Buy
3,227
+375
+13% +$48.3K 0.18% 140
2024
Q1 		$376K Sell
2,852
-790
-22% -$97.4K 0.2% 70
2023
Q4 		$397K Buy
3,642
+447
+14% +$46.4K 0.21% 78
2023
Q3 		$329K Buy
3,195
+132
+4% +$14.2K 0.18% 91
2023
Q2 		$353K Buy
3,063
+812
+36% +$92.2K 0.2% 86
2023
Q1 		$238K Sell
2,251
-1,907
-46% -$206K 0.15% 111
2022
Q4 		$461K Sell
4,158
-388
-9% -$39.7K 0.3% 65
2022
Q3 		$391K Buy
4,546
+777
+21% +$69.4K 0.26% 66
2022
Q2 		$344K Buy
+3,769
New +$334K 0.24% 70

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s MRK Position: Q1 2026 in Review

Thrive Capital Management (Pennsylvania) reduced its Merck (MRK) stake by 7.4% in Q1 2026, selling an estimated $377K and leaving 41,019 shares worth $4.93M. The position accounts for 1.08% of the portfolio, ranked #20.

Thrive Capital Management (Pennsylvania) first reported a position in MRK in Q2 2022 and has held it in 16 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Thrive Capital Management (Pennsylvania) held 41,019 shares of Merck worth $4.93M as of Q1 2026.
  • Thrive Capital Management (Pennsylvania) sold 3,269 Merck shares in Q1 2026, an estimated $377K.
  • Merck made up 1.08% of Thrive Capital Management (Pennsylvania)'s portfolio in Q1 2026, its #20 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Merck in Q2 2022 and has held it in 16 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2026, filed 27 Apr 2026.